These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

64 related articles for article (PubMed ID: 776138)

  • 21. [Echocardiography with angiotensin administration in the diagnosis of adriamycin-induced cardiomyopathy].
    Göldel N; Autenrieth G; Werdan K; Knesewitsch P; Wilmanns W
    Z Kardiol; 1989 May; 78(5):320-7. PubMed ID: 2735093
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Cardiotoxicity of drugs used in the treatment of malignant neoplasms].
    Ciubra-Niczewska E
    Pol Tyg Lek; 1983 Jan; 38(1):35-7. PubMed ID: 6866817
    [No Abstract]   [Full Text] [Related]  

  • 23. Cardiac effects of doxorubicin therapy of neoplasms.
    Ugoretz RJ
    JAMA; 1976 Jul; 236(3):295-6. PubMed ID: 947037
    [No Abstract]   [Full Text] [Related]  

  • 24. Phase II evaluation of adriamycin in human neoplasia.
    O'Bryan RM; Luce JK; Talley RW; Gottlieb JA; Baker LH; Bonadonna G
    Cancer; 1973 Jul; 32(1):1-8. PubMed ID: 4716773
    [No Abstract]   [Full Text] [Related]  

  • 25. Combined cardiotoxicity of adriamycin and x-radiation.
    Fajardo LF; Eltringham JR; Steward JR
    Lab Invest; 1976 Jan; 34(1):86-96. PubMed ID: 1246126
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Adriamycin: review of clinical pharmacology and toxicity of an effective anticancer drug.
    Riggs CE; Sharp SA
    Iowa Med; 1987 May; 77(5):242, 245-51. PubMed ID: 3298138
    [No Abstract]   [Full Text] [Related]  

  • 27. Cardiac transplantation for doxorubicin cardiotoxicity.
    Grady KL; Jassak PF; Varricchio CG
    Prog Cardiovasc Nurs; 1987; 2(2):66-70. PubMed ID: 3295864
    [No Abstract]   [Full Text] [Related]  

  • 28. Feasibility and pharmacokinetic study of infusional dexrazoxane and dose-intensive doxorubicin administered concurrently over 96 h for the treatment of advanced malignancies.
    Chow WA; Synold TW; Tetef ML; Longmate J; Frankel P; Lawrence J; Al-Khadimi Z; Leong L; Lim D; Margolin K; Morgan RJ; Raschko J; Shibata S; Somlo G; Twardowski P; Yen Y; Doroshow JH
    Cancer Chemother Pharmacol; 2004 Sep; 54(3):241-8. PubMed ID: 15173955
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Calcium antagonists: effects on cardiotoxicity caused by adriamycin. Preliminary trials].
    Polverino W; Basso A; Muto P; Genovese A; Perrone V; Apice G; Farace J
    Minerva Cardioangiol; 1983 Mar; 31(3):115-20. PubMed ID: 6856096
    [No Abstract]   [Full Text] [Related]  

  • 30. Doxorubicin cardiomyopathy: underlying cause of interferon-induced cardiac dysfunction?
    Geffen DB; Liel-Cohen N
    Isr Med Assoc J; 2007 Sep; 9(9):690; author reply 690-1. PubMed ID: 17939640
    [No Abstract]   [Full Text] [Related]  

  • 31. Melphalan versus adriamycin in the treatment of advanced carcinoma of the ovary.
    de Palo GM; de Lena M; Di Re F; Luciani L; Valagussa P; Bonadonna G
    Surg Gynecol Obstet; 1975 Dec; 141(6):899-902. PubMed ID: 1103333
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Comparative analysis of noninvasive cardiac parameters in the detection and evaluation of adriamycin cardiotoxicity.
    Shuman RD; Ettinger DS; Abeloff MD; Livengood SV; Fortuin NJ
    Johns Hopkins Med J; 1981 Aug; 149(2):57-63. PubMed ID: 7253365
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Cardiodynamic effects during acute adriamycin administration].
    Mazzola C; Berardinelli P; Clini V; Cavallaro GF
    G Ital Chemioter; 1975; 22(1-2):33-8. PubMed ID: 1235350
    [No Abstract]   [Full Text] [Related]  

  • 34. Peripartum heart failure in a patient treated previously with doxorubicin.
    Davis LE; Brown CE
    Obstet Gynecol; 1988 Mar; 71(3 Pt 2):506-8. PubMed ID: 3162299
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Delayed toxic myocardiopathy caused by adriamycin].
    Munárriz B; Molins C; Montalar J; Algarra FJ
    Med Clin (Barc); 1992 Dec; 99(19):757. PubMed ID: 1460949
    [No Abstract]   [Full Text] [Related]  

  • 36. [THP-adriamycin: status of the clinical development of a new anthracycline in France].
    Herait P
    Pathol Biol (Paris); 1990 Jan; 38(1):64-8. PubMed ID: 2308782
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Orthotopic heart transplantation eleven years after left pneumonectomy.
    Goenen M; Baele P; Lintermans J; Lecomte C; Col J; Ponlot R; Schoevardts JC; Chalant C
    J Heart Transplant; 1988; 7(4):309-11. PubMed ID: 3049983
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Reversible doxorubicin-induced congestive heart failure.
    Cohen M; Kronzon I; Lebowitz A
    Arch Intern Med; 1982 Aug; 142(8):1570-1. PubMed ID: 7103641
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [New cytostatics: bleomycin and adriamycin (author's transl)].
    Nagel GA
    Ther Umsch; 1973 Sep; 30(9):657-62. PubMed ID: 4127379
    [No Abstract]   [Full Text] [Related]  

  • 40. The clinical evaluation of analogs--III. Anthracyclines.
    Carter SK
    Cancer Chemother Pharmacol; 1980; 4(1):5-10. PubMed ID: 7363403
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 4.